Literature DB >> 19642957

Prevalence and determinants of sunburn in Queensland.

Carla Rogers1, Marina Kvaskoff, Tracey DiSipio, Danny Youlden, David Whiteman, Elizabeth Eakin, Philippa H Youl, Joanne Aitken, Lyn Fritschi.   

Abstract

ISSUE ADDRESSED: Australia records the highest incidence of skin cancer in the world. In response to this, public education campaigns have incorporated messages about reducing sun exposure and avoiding sunburn. This study sought to describe the prevalence of and factors associated with sunburn in Queensland residents.
METHODS: The Queensland Cancer Risk Study was a population-based, cross-sectional survey of 9,298 respondents conducted via computer-assisted telephone interview during 2004. Sunburn prevalence and its association with socio-demographics and skin cancer risk variables were examined.
RESULTS: More than two-thirds (70.4%) of respondents reported at least one episode of sunburn in the past 12 months, and one in 10 respondents reported at least one episode of severe sunburn in the past 12 months. Experiences of sunburn on two or more occasions were reported more frequently by males than females (57.6% versus 46.5%, p<0.001), and by nearly two-thirds (65.8%) of those aged 20-39 years compared to 48.0% of 40-59 year olds, and 26.7% of 60-75 year olds (p<0.001). Episodes of sunburn were strongly associated with being male (OR=2.20 95%CI 1.84-2.63) and being aged 20 to 39 years compared to 60 to 75 years (OR=9.79, 95%CI=7.66-12.50).
CONCLUSIONS: Sunburn remains highly prevalent among Queensland residents particularly among men and in the younger age groups.

Entities:  

Mesh:

Year:  2009        PMID: 19642957     DOI: 10.1071/he09102

Source DB:  PubMed          Journal:  Health Promot J Austr        ISSN: 1036-1073


  1 in total

1.  Gender differences and inflammation: an in vitro model of blood cells stimulation in prepubescent children.

Authors:  Georges Ja Casimir; Fabienne Heldenbergh; Laurence Hanssens; Sandra Mulier; Claudine Heinrichs; Nicolas Lefevre; Julie Désir; Francis Corazza; Jean Duchateau
Journal:  J Inflamm (Lond)       Date:  2010-06-02       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.